CANNASSURE THERAPEUTICS LTD Inactive Instrument
Cannassure Therapeutics Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
CSURE
IL0001110134
Healthcare Facilities & Services
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 33.78 124.77 46 | Sales 2023 | 11 40.62 14.98 | Capitalization | 4M 14.77M 5.45M |
|---|---|---|---|---|---|
| Net income 2022 | -5M -18.47M -6.81M | Net income 2023 | -1M -3.69M -1.36M | EV / Sales 2022 | 1,023,292 x |
| Net Debt 2022 | 29.96M 111M 40.8M | Net Debt 2023 | 2.43M 8.99M 3.31M | EV / Sales 2023 | 585,038 x |
| P/E ratio 2022 |
-0.84
x | P/E ratio 2023 |
-2.24
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 101.78% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 22-03-30 |
Nir Peles
CHM | Chairman | 51 | 18-12-03 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 19-06-25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 71 | 18-12-03 |
Nir Peles
CHM | Chairman | 51 | 18-12-03 |
Varda Kalal
BRD | Director/Board Member | 56 | 22-02-13 |
Cannassure Therapeutics Ltd, formerly Direct Capital Investments Ltd, is an Israel-based real estate company. The Company has two main business activities; Yielding real estate and real estate investments in which the Company, directly and through its subsidiaries; locates, purchases, rents, upgrades and manages real estate. The Company and its subsidiaries have investments and property rights in Germany, Serbia, India, Kazakhstan, Latvia and Israel.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 339M | |
| +40.21% | 289M | |
| +42.80% | 280M | |
| +44.19% | 188M | |
| +149.62% | 146M | |
| +49.96% | 136M | |
| -37.59% | 129M | |
| -28.57% | 121M | |
| +11.54% | 97.22M |
